Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Laboratory Developed Tests Market, by Application
1.4.2 North America Laboratory Developed Tests Market, by Technology
1.4.3 North America Laboratory Developed Tests Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.
Chapter 5. North America Laboratory Developed Tests Market by Application
5.1 North America Oncology Market by Country
5.2 North America Genetic Disorders/Inherited Disease Market by Country
5.3 North America Infectious & Parasitic Diseases Market by Country
5.4 North America Endocrine Market by Country
5.5 North America Immunology Market by Country
5.6 North America Nutritional & Metabolic Disease Market by Country
5.7 North America Cardiology Market by Country
5.8 North America Mental/Behavioral Disorder Market by Country
5.9 North America Pediatrics-specific Testing Market by Country
5.1 North America Others Market by Country
Chapter 6. North America Laboratory Developed Tests Market by Technology
6.1 North America Molecular Diagnostics Market by Country
6.2 North America Immunoassays Market by Country
6.3 North America Hematology & Coagulation Market by Country
6.4 North America Microbiology Market by Country
6.5 North America Clinical Chemistry Market by Country
6.6 North America Histology/Cytology Market by Country
6.7 North America Flow Cytometry Market by Country
6.8 North America Mass Spectroscopy Market by Country
6.9 North America Others Market by Country
Chapter 7. North America Laboratory Developed Tests Market by Country
7.1 US Laboratory Developed Tests Market
7.1.1 US Laboratory Developed Tests Market by Application
7.1.2 US Laboratory Developed Tests Market by Technology
7.2 Canada Laboratory Developed Tests Market
7.2.1 Canada Laboratory Developed Tests Market by Application
7.2.2 Canada Laboratory Developed Tests Market by Technology
7.3 Mexico Laboratory Developed Tests Market
7.3.1 Mexico Laboratory Developed Tests Market by Application
7.3.2 Mexico Laboratory Developed Tests Market by Technology
7.4 Rest of North America Laboratory Developed Tests Market
7.4.1 Rest of North America Laboratory Developed Tests Market by Application
7.4.2 Rest of North America Laboratory Developed Tests Market by Technology
Chapter 8. Company Profiles
8.1 Neogenomics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Guardant Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Quest Diagnostics Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.5 SWOT Analysis
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segment and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bio-Rad laboratories, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Eurofins Scientific SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis
Unique Offerings 